Brief: Integral Diagnostics Sees FY24 Replacement And Growth Capex Between A$30.0M To A$40.0M.

Integral Diagnostics

20/02/2024 24:14

Feb 20 (Reuters) - Integral Diagnostics Ltd  IDX.AX :
    * FY24 REPLACEMENT AND GROWTH CAPEX EXPECTED BETWEEN A$30.0M
TO
A$40.0M.
    * DECLARED DIVIDENDS PER SHARE OF 2.5 AU CENTS
    * IMPROVEMENT INITIATIVES TO LEAD TO IMPROVEMENT IN 2H FY24
TRADING PERFORMANCE AND OPERATING EBITDA MARGIN VERSUS H1 FY24
    * FOR JANUARY 2024 AND UP TO AND INCLUDING 15 FEB 2024,
ACHIEVED
SOLID REVENUE GROWTH 11.6%

Source text for Eikon:  ID:nASXsLRf3 
Further company coverage:  IDX.AX